Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (95,765)	$ (100,916)	$ (124,518)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	11,126	11,703	12,176
Stock-based compensation	126,682	139,819	142,862
Amortization of deferred commissions	54,392	53,072	49,366
Non-cash operating lease costs	9,526	9,468	9,305
Amortization of debt issuance costs	2,144	1,514	1,486
Amortization of premium and accretion of discount on marketable securities, net	(12,690)	(9,354)	(344)
Acquired in-process research and development	6,653	0	0
Gain from sale of property and equipment	0	0	(21)
Changes in assets and liabilities:
Trade receivables	(23,716)	(33,137)	(18,800)
Prepaid expenses and other short-term assets	(35,332)	(21,459)	(6,161)
Deferred commissions	(59,820)	(53,505)	(49,135)
Other long-term assets	347	(577)	502
Trade payables	3,641	(2,290)	(2,362)
Accrued expenses and other short-term liabilities	17,317	(5,278)	(9,115)
Deferred revenues	110,389	69,882	5,266
Other long-term liabilities	306	474	1,364
Net cash provided by operating activities	115,200	59,416	11,871
Cash flows from investing activities:
Proceeds from maturities of marketable securities	308,840	301,350	41,600
Proceeds from sales of marketable securities	111,552	0	0
Investment in marketable securities	(949,841)	(517,948)	(277,871)
Proceeds from short-term and long-term deposits	34,795	214,444	15,961
Investment in short-term and long-term deposits	(24,254)	(135,823)	(142,566)
Purchase of in-process research and development	(6,653)	0	0
Proceeds from sale of property and equipment	0	0	21
Purchases of property and equipment	(6,694)	(5,099)	(11,396)
Net cash used in investing activities	(532,255)	(143,076)	(374,251)
Cash flows from financing activities:
Proceeds from employee stock plans	16,082	11,537	11,940
Taxes paid related to net share settlement of equity awards	(38,295)	(21,415)	(31,077)
Repurchase of common stock	0	(43,522)	(56,444)
Proceeds from issuance of convertible senior notes, net of issuance costs	449,635	0	0
Purchases of capped calls	(55,522)	0	0
Net cash provided by (used in) financing activities	371,900	(53,400)	(75,581)
Decrease in cash and cash equivalents	(45,155)	(137,060)	(437,961)
Cash and cash equivalents at beginning of period	230,740	367,800	805,761
Cash and cash equivalents at end of period	185,585	230,740	367,800
Supplemental disclosure of cash flow information:
Cash paid for income taxes	24,249	16,089	7,354
Cash paid for interest	3,193	3,196	3,167
Lease liabilities arising from obtaining right-of-use assets	3,148	3,166	1,625
Common stock issued for debt conversion	$ 1,501	$ 0	$ 0